CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 118 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $399,000 | +35.3% | 86,400 | -2.1% | 0.01% | +25.0% |
| Q4 2020 | $295,000 | +12.2% | 88,282 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $263,000 | -87.4% | 88,282 | -80.4% | 0.00% | -86.2% |
| Q2 2020 | $2,080,000 | +20.0% | 450,182 | 0.0% | 0.03% | +3.6% |
| Q1 2020 | $1,734,000 | +2.1% | 450,182 | 0.0% | 0.03% | +64.7% |
| Q4 2019 | $1,698,000 | +24157.1% | 450,182 | +37986.5% | 0.02% | – |
| Q3 2019 | $7,000 | +40.0% | 1,182 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -28.6% | 1,182 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | +133.3% | 1,182 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 1,182 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | 0.0% | 1,182 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | +33.3% | 1,182 | +8.1% | 0.00% | – |
| Q1 2018 | $3,000 | -25.0% | 1,093 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | – | 1,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |